Amerikanische Gesellschaft für Hirudotherapie
Blutungs- / Transfusionsrisiko
Aeromonas-Infektionsrisiko
Nur Einmalgebrauch + Biohazard-Entsorgung

Forschungsbibliothek

Kuratierte Übersichten peer-reviewter Forschung mit Relevanz für die Hirudotherapie

Zuletzt aktualisiert: May 27, 2026Geprüft von: Andrei Dokukin, MD
Research knowledge base

ASH structured research registries

In addition to 10059+ long-form research articles below, ASH curates 5 structured registries with cross-linking:

Editorial transparency & research roadmap

ASH treats this library as a living dataset. Current import baseline: 10059 long-form articles plus 449 metadata-imported PubMed/DOI records, with a public 10,000-article ingestion target. The pages below explain how we grade evidence, what PMIDs are still unverified, and where the corpus is going next.

Letzte Aktualisierung: June 18, 2026

Die ASH-Forschungsbibliothek indexiert derzeit 269 peer-reviewte Publikationen mit Relevanz für die Hirudotherapie und umfasst klinische Studien, mikrochirurgische Ergebnisse, Genomik & Proteomik, Arzneimittelentwicklung, Speichel-Pharmakologie sowie Sicherheit & Infektionskontrolle. Jeder Artikel enthält eine vollständige Zitation sowie – sofern verfügbar – einen Link zur Primärquelle. Eine kuratierte Auswahl (50+ Einträge) ist in Hirudopedia nach Indikation, Evidenzgrad und Studiendesign vollständig annotiert.

Evidenz-Disziplin

Alle Artikel werden anhand der Primärquellen überprüft. Präklinische Forschung wird klar von klinischer Evidenz abgegrenzt. Der regulatorische Kontext (FDA-zugelassen vs. experimentell) wird, soweit zutreffend, vermerkt.

Forschungskategorien

Antimikrobielle Resistenz

AMPs, Antibiotika-Synergie und neuartige Ansätze gegen arzneimittelresistente Pathogene.

248 Artikel

Speichel-Pharmakologie

Bioaktive Verbindungen im Blutegelspeichel – Entdeckung, Charakterisierung und therapeutisches Potenzial.

968 Artikel

Arzneimittelentwicklung

Translation blutegelabgeleiteter Verbindungen vom Labor in die klinische Anwendung.

3.264 Artikel

Klinische Studien

Randomisierte kontrollierte Studien und systematische Übersichtsarbeiten zu Ergebnissen der Blutegeltherapie.

6.472 Artikel

Sicherheit & Infektionskontrolle

Aeromonas-Überwachung, Prophylaxe-Protokolle und Daten zu unerwünschten Ereignissen.

1.000 Artikel

Genomik & Proteomik

Omics-basierte Entdeckung neuartiger Speichelproteine des Blutegels und ihrer Funktionen.

808 Artikel

Alle Artikel

Showing the 24 most recently added articles. Search or browse all 10,059 articles in the Smart Library (faceted search by topic, evidence grade, year, and verification status), or by category above.

Function of the waterfowl nests as reproduction and living areas for leeches (Annelida: Hirudinea)

Genomik & Proteomik

Ceylan et al. (2021) — Animal reproduction science

Peer-reviewed genomics, proteomics, and molecular research relevant to leech biology and salivary compounds. Indexed in PubMed and verified against the NCBI record.

Analyse lesen →

Correction to: Bacterial Community of the Digestive Tract of the European Medicinal Leech (Hirudo verbana) from the Danube River

Sicherheit & Infektionskontrolle

Neupane et al. (2019) — Microbial ecology

Peer-reviewed safety and infection-control research relevant to leech therapy and microsurgical wound management. Indexed in PubMed and verified against the NCBI record.

Analyse lesen →

Draft Genome Sequence of Pedobacter sp. Strain Hv1, an Isolate from Medicinal Leech Mucosal Castings

Genomik & Proteomik

Ott et al. (2015) — Genome announcements

Peer-reviewed genomics, proteomics, and molecular research relevant to leech biology and salivary compounds. Indexed in PubMed and verified against the NCBI record.

Analyse lesen →

Effect of medicinal leeches' antigens on the proliferative response of human blood mononuclear cells and cytokine production in vitro

Klinische Studien

Frolov et al. (2015) — Annals of parasitology

Peer-reviewed clinical and outcomes research relevant to medicinal leech therapy and its biology. Indexed in PubMed and verified against the NCBI record.

Analyse lesen →

Complete Genome Sequence of the Novel Leech Symbiont Mucinivorans hirudinis M3T

Genomik & Proteomik

Nelson et al. (2015) — Genome announcements

Peer-reviewed genomics, proteomics, and molecular research relevant to leech biology and salivary compounds. Indexed in PubMed and verified against the NCBI record.

Analyse lesen →

Spatial and temporal population dynamics of a naturally occurring two-species microbial community inside the digestive tract of the medicinal leech

Genomik & Proteomik

Kikuchi et al. (2007) — Applied and environmental microbiology

Peer-reviewed genomics, proteomics, and molecular research relevant to leech biology and salivary compounds. Indexed in PubMed and verified against the NCBI record.

Analyse lesen →

Venous engorged tissue flaps treated with medicinal leeches

Klinische Studien

Rodgers et al. (1992) — Ophthalmic plastic and reconstructive surgery

Peer-reviewed clinical and outcomes research relevant to medicinal leech therapy and its biology. Indexed in PubMed and verified against the NCBI record.

Analyse lesen →

Leech therapy in the management of acute venous congestion of an infant's lower limb

Klinische Studien

Weinfeld et al. (1998) — Plastic and reconstructive surgery

Peer-reviewed clinical and outcomes research relevant to medicinal leech therapy and its biology. Indexed in PubMed and verified against the NCBI record.

Analyse lesen →

Bivalirudin for unsalvageable venous congestion or obstruction in head and neck free flap reconstruction

Arzneimittelentwicklung

Harris et al. (2024) — Oral oncology

Peer-reviewed pharmacology and drug-development research relevant to anticoagulants and leech-derived compounds. Indexed in PubMed and verified against the NCBI record.

Analyse lesen →

Recombinant hirudin and PAR-1 regulate macrophage polarisation status in diffuse large B-cell lymphoma

Arzneimittelentwicklung

Pei et al. (2024) — BMC biotechnology

Peer-reviewed pharmacology and drug-development research relevant to anticoagulants and leech-derived compounds. Indexed in PubMed and verified against the NCBI record.

Analyse lesen →

Comment on: Bivalirudin during thrombolysis with catheter-directed tPA in a heparin-refractory patient: A case report

Arzneimittelentwicklung

Han (2024) — Pediatric blood & cancer

Peer-reviewed pharmacology and drug-development research relevant to anticoagulants and leech-derived compounds. Indexed in PubMed and verified against the NCBI record.

Analyse lesen →

Bivalirudin: The misunderstood alternative to heparin

Arzneimittelentwicklung

Faraoni et al. (2024) — Paediatric anaesthesia

Peer-reviewed pharmacology and drug-development research relevant to anticoagulants and leech-derived compounds. Indexed in PubMed and verified against the NCBI record.

Analyse lesen →

Unresponsiveness of Activated Partial Thromboplastin Time to Bivalirudin in Adults Receiving Extracorporeal Membrane Oxygenation

Arzneimittelentwicklung

Jatis et al. (2024) — ASAIO journal (American Society for Artificial Internal Organs : 1992)

Peer-reviewed pharmacology and drug-development research relevant to anticoagulants and leech-derived compounds. Indexed in PubMed and verified against the NCBI record.

Analyse lesen →

Protein-Engineered Hirudins with Enhanced Anticoagulant Activities Developed by a Molecular Integrative Approach

Klinische Studien

Sun et al. (2024) — Journal of medicinal chemistry

Peer-reviewed clinical and outcomes research relevant to medicinal leech therapy and its biology. Indexed in PubMed and verified against the NCBI record.

Analyse lesen →

Use of bivalirudin after initial heparin management among adult patients on long-term venovenous extracorporeal support as a bridge to lung transplant: A case series

Arzneimittelentwicklung

Halawi et al. (2024) — Pharmacotherapy

Peer-reviewed pharmacology and drug-development research relevant to anticoagulants and leech-derived compounds. Indexed in PubMed and verified against the NCBI record.

Analyse lesen →

Bivalirudin Stability in Citrated Plasma and Citrated Whole Blood

Arzneimittelentwicklung

Bruzdoski et al. (2024) — Archives of pathology & laboratory medicine

Peer-reviewed pharmacology and drug-development research relevant to anticoagulants and leech-derived compounds. Indexed in PubMed and verified against the NCBI record.

Analyse lesen →

Comparison of bleeding and thrombotic outcomes in veno-venous extracorporeal membrane oxygenation: Heparin versus bivalirudin

Arzneimittelentwicklung

Kartika et al. (2024) — European journal of haematology

Peer-reviewed pharmacology and drug-development research relevant to anticoagulants and leech-derived compounds. Indexed in PubMed and verified against the NCBI record.

Analyse lesen →

Management of Bivalirudin Dosing and Replacement Fluid During Therapeutic Plasma Exchange in Children on Extracorporeal Membrane Oxygenation

Arzneimittelentwicklung

Chomat et al. (2024) — ASAIO journal (American Society for Artificial Internal Organs : 1992)

Peer-reviewed pharmacology and drug-development research relevant to anticoagulants and leech-derived compounds. Indexed in PubMed and verified against the NCBI record.

Analyse lesen →

Editorial: Bivalirudin versus unfractionated heparin in acute myocardial infarction: Why are we still debating?

Arzneimittelentwicklung

Cohen et al. (2024) — Cardiovascular revascularization medicine : including molecular interventions

Peer-reviewed pharmacology and drug-development research relevant to anticoagulants and leech-derived compounds. Indexed in PubMed and verified against the NCBI record.

Analyse lesen →

One-year clinical outcomes of bivalirudin versus unfractionated heparin in patients with type 2 diabetes undergoing elective percutaneous coronary intervention

Arzneimittelentwicklung

Li et al. (2023) — Diabetes & metabolic syndrome

Peer-reviewed pharmacology and drug-development research relevant to anticoagulants and leech-derived compounds. Indexed in PubMed and verified against the NCBI record.

Analyse lesen →

Editorial: Bivalirudin with post-procedural infusion: Should the Guidelines change to keep up with the data?

Arzneimittelentwicklung

Lipinski (2023) — Cardiovascular revascularization medicine : including molecular interventions

Peer-reviewed pharmacology and drug-development research relevant to anticoagulants and leech-derived compounds. Indexed in PubMed and verified against the NCBI record.

Analyse lesen →

The effect of bivalirudin on coagulation function in male patients with coronary heart disease undergoing percutaneous coronary intervention

Arzneimittelentwicklung

Dequan et al. (2023) — Pakistan journal of pharmaceutical sciences

Peer-reviewed pharmacology and drug-development research relevant to anticoagulants and leech-derived compounds. Indexed in PubMed and verified against the NCBI record.

Analyse lesen →

Anticoagulation strategies in patients with extracorporeal membrane oxygenation: A network meta-analysis and systematic review

Klinische Studien

Chen et al. (2023) — Pharmacotherapy

Peer-reviewed clinical and outcomes research relevant to medicinal leech therapy and its biology. Indexed in PubMed and verified against the NCBI record.

Analyse lesen →

Anticoagulation Management in Temporary Mechanical Circulatory Support Devices

Klinische Studien

Yin (2023) — Texas Heart Institute journal

Peer-reviewed clinical and outcomes research relevant to medicinal leech therapy and its biology. Indexed in PubMed and verified against the NCBI record.

Analyse lesen →

Eine Publikation zur Begutachtung vorschlagen

Kennen Sie eine relevante Publikation zur Hirudotherapie? Wir nehmen Vorschläge für unsere Forschungsbibliothek gerne entgegen.

Kontaktieren Sie uns →

Diese Website stellt Bildungsinformationen bereit und ist weder eine medizinische Beratung noch eine Diagnose oder Behandlungsempfehlung. Die medizinische Blutegeltherapie ist mit klinisch relevanten Risiken verbunden und sollte ausschließlich von qualifizierten Klinikerinnen und Klinikern unter institutionell genehmigten Protokollen durchgeführt werden. Die FDA-510(k)-Zulassung für medizinische Blutegel ist auf bestimmte Indikationen beschränkt; experimentelle und Off-Label-Diskussionen werden entsprechend gekennzeichnet. Für patientenspezifische Beratung wenden Sie sich an eine qualifizierte Gesundheitsfachkraft.